|  Help  |  About  |  Contact Us

Publication : CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo.

First Author  Rossi M Year  2015
Journal  Proc Natl Acad Sci U S A Volume  112
Issue  49 Pages  E6818-24
PubMed ID  26598688 Mgi Jnum  J:228130
Mgi Id  MGI:5705418 Doi  10.1073/pnas.1519430112
Citation  Rossi M, et al. (2015) CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo. Proc Natl Acad Sci U S A 112(49):E6818-24
abstractText  G protein-coupled receptors (GPCRs) regulate virtually all physiological functions including the release of insulin from pancreatic beta-cells. beta-Cell M3 muscarinic receptors (M3Rs) are known to play an essential role in facilitating insulin release and maintaining proper whole-body glucose homeostasis. As is the case with other GPCRs, M3R activity is regulated by phosphorylation by various kinases, including GPCR kinases and casein kinase 2 (CK2). At present, it remains unknown which of these various kinases are physiologically relevant for the regulation of beta-cell activity. In the present study, we demonstrate that inhibition of CK2 in pancreatic beta-cells, knockdown of CK2alpha expression, or genetic deletion of CK2alpha in beta-cells of mutant mice selectively augmented M3R-stimulated insulin release in vitro and in vivo. In vitro studies showed that this effect was associated with an M3R-mediated increase in intracellular calcium levels. Treatment of mouse pancreatic islets with CX4945, a highly selective CK2 inhibitor, greatly reduced agonist-induced phosphorylation of beta-cell M3Rs, indicative of CK2-mediated M3R phosphorylation. We also showed that inhibition of CK2 greatly enhanced M3R-stimulated insulin secretion in human islets. Finally, CX4945 treatment protected mice against diet-induced hyperglycemia and glucose intolerance in an M3R-dependent fashion. Our data demonstrate, for the first time to our knowledge, the physiological relevance of CK2 phosphorylation of a GPCR and suggest the novel concept that kinases acting on beta-cell GPCRs may represent novel therapeutic targets.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

7 Bio Entities

Trail: Publication

0 Expression